Search results for "Biomarkers"
Studies look at new and old scores, biomarkers for predicting COVID-19 outcomes
The SOFA score did not perform well for predicting mortality in patients admitted with COVID-19, multiple recent studies found, but levels of d-dimer and C-reactive protein had prognostic value, according to the latest research.
https://acphospitalist.acponline.org/weekly/archives/2021/02/24/1.htm
24 Feb 2021
Research on strokes and readmissions in COVID-19, updated guidance from NIH and SSC
One study showed that strokes were rare in COVID-19 patients, while another didn't find any connection between fever or biomarkers before discharge and readmissions. The NIH and the Surviving Sepsis Campaign (SSC) updated their COVID-19 critical care recommendations.
https://acphospitalist.acponline.org/weekly/archives/2021/02/10/1.htm
10 Feb 2021
New data on tocilizumab, convalescent plasma, anticoagulation for COVID-19
Recent studies found that tocilizumab was potentially harmful for ICU patients, indicated that convalescent plasma works better with higher antibody titers delivered earlier, and offered conflicting findings on anticoagulation. Other research compared mortality from COVID-19 over time.
https://acphospitalist.acponline.org/weekly/archives/2021/01/27/1.htm
27 Jan 2021
New warnings on benzodiazepines
Recalls, warnings, and approvals.
https://acphospitalist.acponline.org/archives/2020/11/fda-update-new-warnings-on-benzodiazepines.htm
15 Nov 2020
COVID-19 flu guidance, data on convalescent plasma, cardiac effects, and clot risk
Flu testing and treatment advice came from the NIH, convalescent plasma failed in a trial, new studies suggested looking out for myocardial injury and not overdoing thromboprophylaxis, and remdesivir got full approval, among other COVID-19 news.
https://acphospitalist.acponline.org/weekly/archives/2020/10/28/1.htm
28 Oct 2020
Mixed findings on remdesivir for COVID-19, news on SARS-CoV-2 vaccines
Among other news this week, the NIH and the WHO released results from remdesivir trials, more negative findings were published for hydroxychloroquine, and ACP and Annals of Internal Medicine held a vaccine forum featuring Anthony S. Fauci, MD, MACP, and other experts.
https://acphospitalist.acponline.org/weekly/archives/2020/10/21/1.htm
21 Oct 2020
D-dimer, lung ultrasound, and ICU protocols all helpful, latest COVID-19 research says
D-dimer predicted clots in ICU patients better than scores or other markers, lung ultrasound was an effective triage tool, and a protocol for respiratory failure improved ICU survival early on in the pandemic, recent studies found.
https://acphospitalist.acponline.org/weekly/archives/2020/09/23/1.htm
23 Sep 2020
Combination of biomarkers appears as accurate as troponin plus clinical signs for identifying type 2 MI
Patients with type 2 myocardial infarction (MI) had higher levels of mid-regional pro-atrial natriuretic peptide, C-terminal pro-endothelin-1, mid-regional pro-adrenomedullin, and procalcitonin than patients with type 1 MI.
https://acphospitalist.acponline.org/weekly/archives/2020/09/02/4.htm
2 Sep 2020
PE risk assessment tools modestly effective for estimating mortality, study finds
The Pulmonary Embolism Severity Index (PESI), the simplified PESI (sPESI), the Bova score, and a risk assessment method from the European Society of Cardiology were evaluated.
https://acphospitalist.acponline.org/weekly/archives/2020/09/02/3.htm
2 Sep 2020
Latest COVID-19 research finds benefit from prone positioning, arthritis drugs
Prone positioning was helpful in patients not on mechanical ventilation, and two very small studies found positive outcomes with drugs used to treat rheumatoid arthritis. ACP members can join a bulk purchase of N95s and gowns.
https://acphospitalist.acponline.org/weekly/archives/2020/06/24/1.htm
24 Jun 2020